Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/25/2026

1. NVDA
2. JMKE
3. SPY
4. BABA
5. REF
6. XPEV
7. USO
8. TSLA
9. REAX
10. BA

Go back to Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 2.64 +0.10 (3.94%)
Previous Close $2.54    52 Week High $3.64 
Open $2.56    52 Week Low $0.14 
Day High $2.65    P/E N/A 
Day Low $2.45    EPS $0.00 
Volume 57,050